Related Experiment Video
Updated: Jun 22, 2026
Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
IL-6 release from mouse glia caused by MeHg requires cytosolic phospholipase A2 activation
1Department of Neurobiology and Developmental Sciences, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. changjasony@uams.edu
Abstract:
Methylmercury is a potent neurotoxin that causes severe neurological disorders in fetuses and young children. Recent studies indicated that MeHg could alter levels of immune mediators produced by cells of the central nervous system. Results from this study indicated that MeHg could greatly induce IL-6 release from primary mouse glial cultures. This property was not shared by other cytotoxic heavy metals, such as CdCl(2) or HgCl(2). MeHg was known to induce cytosolic phospholipase A(2) (PLA(2)) activation and expression, and this enzyme was required for IL-6 induction in some experimental systems. Further experiments using structurally distinct pharmacological agents were performed to test the hypothesis that MeHg induced PLA(2) activation was necessary for MeHg induced IL-6 release. Results indicated that AACOCF(3) (>or=10 microM), MAFP (>or=0.625 microM) and BEL (>or=0.625 microM) significantly reduced MeHg induced IL-6 release in glia. However, these PLA(2) inhibitors did not block MeHg induced GSH depletion. These results suggested that PLA(2) activation was required for MeHg to induce glial IL-6 release.
Insights
Methylmercury (MeHg) significantly increases interleukin-6 (IL-6) release from glial cells. This effect is dependent on the activation of cytosolic phospholipase A(2) (PLA(2)), but not on glutathione depletion.
Area of Science:
- Neuroscience
- Toxicology
- Immunology
Background:
- Methylmercury (MeHg) is a potent neurotoxin with adverse effects on fetal and child development.
- MeHg exposure can alter immune mediator production within the central nervous system.
- Glial cells are key players in the central nervous system's immune response.
Purpose of the Study:
- To investigate the role of cytosolic phospholipase A(2) (PLA(2)) in methylmercury-induced IL-6 release from glial cells.
- To determine if PLA(2) activation is a necessary step for MeHg to induce IL-6 production.
- To differentiate the mechanism of IL-6 induction from MeHg-induced glutathione depletion.
Main Methods:
- Primary mouse glial cultures were utilized to study MeHg effects.
- Interleukin-6 (IL-6) release was measured following MeHg exposure.
- Specific PLA(2) inhibitors (AACOCF(3), MAFP, BEL) were used to block PLA(2) activity.
- Glutathione (GSH) levels were assessed to evaluate MeHg's impact on cellular redox state.
Main Results:
- Methylmercury significantly induced IL-6 release from primary mouse glial cultures.
- The PLA(2) inhibitors AACOCF(3), MAFP, and BEL markedly reduced MeHg-induced IL-6 release.
- These PLA(2) inhibitors did not affect MeHg-induced glutathione depletion, suggesting a specific role for PLA(2) in IL-6 induction.
Conclusions:
- Cytosolic phospholipase A(2) (PLA(2)) activation is a critical requirement for methylmercury to induce IL-6 release in glial cells.
- The mechanism of MeHg-induced IL-6 release is distinct from its effects on glutathione levels.
- These findings highlight a specific molecular pathway through which MeHg exerts its inflammatory effects in the central nervous system.
More Related Videos
08:03Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Published on: April 15, 2014
11:19Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Published on: August 18, 2022
